| CAS: | 794572-10-4 | ||||||||
| 分子式: | C25H34N4O3S | ||||||||
| 分子量: | 470.627 | ||||||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||
| M970587 | MACKLIN | ML 184,GPR55激动剂 | 98% | 4815元/25mg; 5808元/250mg; 15556元/100mg; | 咨询 | ||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||
| SML2884 | Sigma-Aldrich | ML184 | ≥98% (HPLC) | 1042.98元/5 MG; 3365.56元/25 MG; | 咨询 | ||||||||||||||||||||||||||
产品说明 生化/生理作用 ML184 (CID2440433) is a selective G-protein coupled receptor GPR55 (LPIR1) agonist (EC50 = 0.26 μM vs. >32 μM toward GPR35 & CB1/2 by cell-based βarr2 recruitment assay; antagonist IC50 = 15.1, 21.8, >32 μM, respectively, against CB2, CB1, GPR35). ML184 is 18-times more potent than lysophosphatidylinositol in stimulating cellular ERK1/2 phosphorylation (GPR55E- & βarr2-GFP-expressing U2OS cells) and is at least 10-times more potent than CID1792197 or CID1172084 (ML185) in inducing PKCβII translocation (GPR55E- & PKCβII-GFP-expressing HEK293 cells). 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||